Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
commercial manufacturing
Pharma
Travere pauses trial enrollment over manufacturing scale-up woes
San Diego’s Travere Therapeutics has run into trouble with its enzyme replacement candidate pegtibatinase thanks to manufacturing scale-up issues.
Fraiser Kansteiner
Sep 27, 2024 9:26am
CDMO Serán nabs $200M investment for commercial plant build-out
Sep 17, 2024 10:20am
UNDBIO earmarks $100M to build insulin plant in West Virginia
Apr 13, 2023 10:20am
Genentech lays off 280 as first biologics plant winds down
Mar 23, 2023 9:40am
Novo Nordisk makes way for more production in North Carolina
Mar 9, 2023 8:49am
Everest debuts $130M mRNA vaccine plant in China
Mar 2, 2023 10:10am
